SCHEMBL20152086

SCHEMBL20152086

c1ccc2c(c1)ccc[n+]2Cc1cc(C[n+]2cccc3ccccc32)cc(C[n+]2cccc3ccccc32)c1

nearest known ligand 0.82

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ACHE P22303 13/20 0.82
BCHE P06276 12/20 0.82
CHRNA7 P36544 2/20 0.59
CHRNA10 Q9GZZ6 2/20 0.59
CHRNA9 Q9UGM1 2/20 0.59
MEN1 O00255 1/20 0.57
POLB P06746 1/20 0.57
APOBEC3A P31941 1/20 0.57
KMT2A Q03164 1/20 0.57
APOBEC3G Q9HC16 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127587 0.88 ACHE (0.76) ACHEBCHEMEN1POLBAPOBEC3A
SCHEMBL29729955 0.88 ACHE (0.76) ACHEBCHEMEN1POLBAPOBEC3A
Hydrochloric Acid SCHEMBL1071121 0.86 ACHE (0.73) ACHEBCHEMEN1POLBAPOBEC3A
Hydrochloric Acid SCHEMBL29943765 0.86 ACHE (0.73) ACHEBCHEMEN1POLBAPOBEC3A
Bromide SCHEMBL1069897 0.86 ACHE (0.79) ACHEBCHEMEN1POLBAPOBEC3A
SCHEMBL21381177 0.84 ACHE (0.67) ACHEBCHEMEN1POLBAPOBEC3A
SCHEMBL18320448 0.81 ACHE (0.67) ACHEBCHEMEN1POLBAPOBEC3A
SCHEMBL20263107 0.81 ACHE (0.67) ACHEBCHEMEN1POLBAPOBEC3A
SCHEMBL15625753 0.81 BCHE (0.63) ACHEBCHEMEN1POLBAPOBEC3A
SCHEMBL20657095 0.81 ACHE (0.67) ACHEBCHEMEN1POLBAPOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180135187-A1 Corrosion Inhibition SCHLUMBERGER TECHNOLOGY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180135187-A1 Corrosion Inhibition SOD1, AOC1, NOX1 ACHE 837/4885BCHE 3671/4885CHRNA7 2084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.